Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

被引:7
|
作者
Veldhuijzen, Evalien [1 ]
Walraven, Iris [2 ]
Belderbos, Jose [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands
来源
JMIR CANCER | 2021年 / 7卷 / 03期
关键词
PRO-CTCAE; lung cancer; side effects; patient-reported outcomes; PROM; symptomatic adverse events; QUALITY-OF-LIFE; CONTENT VALIDITY; CLINICAL-TRIALS; PRO; QUESTIONNAIRE; RELIABILITY; PREVALENCE; DISTRESS; THERAPY; QLQ-C30;
D O I
10.2196/26574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) item library covers a wide range of symptoms relevant to oncology care. There is a need to select a subset of items relevant to specific patient populations to enable the implementation of PRO-CTCAE-based symptom monitoring in clinical practice. Objective: The aim of this study is to develop a PRO-CTCAE-based subset relevant to patients with lung cancer that can be used for monitoring during multidisciplinary clinical practice. Methods: The PRO-CTCAE-based subset for patients with lung cancer was generated using a mixed methods approach based on the European Organization for Research and Treatment of Cancer guidelines for developing questionnaires, comprising a literature review and semistructured interviews with both patients with lung cancer and health care practitioners (HCPs). Both patients and HCPs were queried on the relevance and impact of all PRO-CTCAE items. The results were summarized, and after a final round of expert review, a selection of clinically relevant items for patients with lung cancer was made. Results: A heterogeneous group of patients with lung cancer (n=25) from different treatment modalities and HCPs (n=22) participated in the study. A final list of eight relevant PRO-CTCAE items was created: decreased appetite, cough, shortness of breath, fatigue, constipation, nausea, sadness, and pain (general). Conclusions: On the basis of the literature and both professional and patient input, a subset of PRO-CTCAE items has been identified for use in patients with lung cancer in clinical practice. Future work is needed to confirm the validity and effectiveness of this PRO-CTCAE-based lung cancer subset internationally and in real-world clinical practice settings.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
    Movsas, Benjamin
    JAMA ONCOLOGY, 2015, 1 (08) : 1059 - 1060
  • [2] Development of the US NCI patient-reported outcomes version of the common terminology criteria for adverse events
    Dueck, Amylou C.
    Basch, Ethan
    Mitchell, Sandra A.
    ANNALS OF ONCOLOGY, 2015, 26 : 26 - 26
  • [3] Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
    Reeve, Bryce B.
    McFatrich, Molly
    Mack, Jennifer W.
    Maurer, Scott H.
    Jacobs, Shana S.
    Freyer, David R.
    Withycombe, Janice S.
    Baker, Justin N.
    Castellino, Sharon M.
    Lin, Li
    Lucas, Nicole R.
    Hinds, Pamela S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (11): : 1143 - 1152
  • [4] Responsiveness of Items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Mendoza, Tito R.
    Bennett, Antonia V.
    Rogak, Lauren
    Atkinson, Thomas M.
    Li, Yuelin
    Reeve, Bryce B.
    Basch, Ethan
    QUALITY OF LIFE RESEARCH, 2014, 23 : 37 - 38
  • [5] Validation study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Dueck, A. C.
    Mendoza, T. R.
    Reeve, B. B.
    Sloan, J. A.
    Cleeland, C. S.
    Hay, J.
    Li, Y.
    O'Mara, A. M.
    Denicoff, A.
    Basch, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
    Yang, Shan-Shan
    Chen, Lei
    Liu, Ying
    Lu, Hai-Jun
    Huang, Bo-Jie
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    Xie, Fang-Yun
    Mao, Yan-Ping
    BMC CANCER, 2021, 21 (01)
  • [7] Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events
    Hinds, Pamela S.
    Pinheiro, Laura C.
    McFatrich, Molly
    Waldron, Mia
    Baker, Justin N.
    Mowbray, Catriona
    Maurer, Scott H.
    Cheng, Yao
    Reeve, Bryce B.
    Wang, Jichuan
    PEDIATRIC BLOOD & CANCER, 2022, 69 (06)
  • [8] Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
    Shan-Shan Yang
    Lei Chen
    Ying Liu
    Hai-Jun Lu
    Bo-Jie Huang
    Ai-Hua Lin
    Ying Sun
    Jun Ma
    Fang-Yun Xie
    Yan-Ping Mao
    BMC Cancer, 21
  • [9] Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure
    Reeve, Bryce B.
    McFatrich, Molly
    Lin, Li
    Lucas, Nicole R.
    Mack, Jennifer W.
    Jacobs, Shana S.
    Withycombe, Janice S.
    Baker, Justin N.
    Freyer, David R.
    Hinds, Pamela S.
    CANCER, 2021, 127 (09) : 1483 - 1494
  • [10] Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer
    Reeve, Bryce B.
    McFatrich, Molly
    Pinheiro, Laura C.
    Freyer, David R.
    Basch, Ethan M.
    Baker, Justin N.
    Withycombe, Janice S.
    Sung, Lillian
    Mack, Jennifer W.
    Waldron, Mia K.
    Mowbray, Catriona
    Palma, Diana
    Hinds, Pamela S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 53 (04) : 759 - 766